Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Ending disease in Africa: control, elimination, and eradication efforts for neglected tropical diseases, scoping review of the literature in the WHO African Region since 1990

World Health Organization, Regional Office for Africa . UHC/UCN Cluster World Health Organization Regional Office for Africa. 2023;
Download PDF
Publication

Maladies tropicales négligées (MTN) : étude de 130 cas de lèpre de 2010 à 2020

Savané M, Keita M, Condé I, et al. Elsevier BV. Annales de Dermatologie et de Vénéréologie - FMC. 2023;
Publication

Pathogenesis, Clinical Considerations, and Treatments: A Narrative Review on Leprosy

Le PH, Philippeaux S, Mccollins T, et al. Springer Science and Business Media LLC. Cureus. 2023;
Download PDF
Publication

Epidemiology and grade 2 disability of leprosy among migrant and resident patients in Guangdong: an unignorable continued transmission of leprosy

Chen L, Zheng D, Li M, et al. Frontiers Media SA. Frontiers in Public Health. 2023;
Download PDF
Publication

Atuação do farmacêutico no tratamento de hanseníase nas unidades básica

Silva CVVDSD, Andrade LGD. Revista Ibero-Americana de Humanidades, Ciencias e Educacao. Revista Ibero-Americana de Humanidades, Ciências e Educação. 2023; 9 (9) : 3847-3857.
Download PDF
Practical material

Pepra med lepra - siste nytt frå leprafronten

Pestpodden . 2023;
Access resource
Publication

Overview of leprosy, including the diagnosis and current available treatments

Srivastav Y, Prajapati A, Jaiswal A, et al. South Asian Academic Publications. Journal of Innovations in Applied Pharmaceutical Science (JIAPS). 2023;
Download PDF
Publication

Childhood borderline lepromatous leprosy: a case report.

Hutahaean G, Susanto M, Napitupulu T, et al. The Turkish journal of pediatrics. 2023; 65 (5) : 862-867.
Download PDF
Publication

Ticks are unlikely to play a role in leprosy transmission in the Comoros (East Africa) as they do not harbour DNA.

Krausser L, Chauvaux E, Van Dyck-Lippens M, et al. Frontiers in medicine. 2023;
Download PDF
Publication

The geographical distribution and socioeconomic risk factors of COVID-19, tuberculosis and leprosy in Fortaleza, Brazil

Taal AT, Barreto JG, Santos de Sousa GD, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2023; 23 (1) : 1-10.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 10
  • Next page ››
Subscribe to Transmission

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD